Geoffrey Greene to Middle Aged
This is a "connection" page, showing publications Geoffrey Greene has written about Middle Aged.
Connection Strength
0.071
-
Estrogen receptor immunocytochemistry in endometrial carcinoma: a prognostic marker for survival. Gynecol Oncol. 1996 Oct; 63(1):28-33.
Score: 0.010
-
Immunocytochemical assay for androgen receptors in prostate cancer: a prospective study of 63 cases with long-term follow-up. Ann Surg Oncol. 1994 Nov; 1(6):495-503.
Score: 0.008
-
Immunocytochemical estrogen and progestin receptor assays in breast cancer with monoclonal antibodies. Histopathologic, demographic, and biochemical correlations and relationship to endocrine response and survival. Cancer. 1990 Oct 15; 66(8):1663-70.
Score: 0.006
-
Immunohistochemical assessment of estrogen and progesterone receptors in stored imprints and cryostat sections of breast carcinomas. Ann Surg. 1989 Aug; 210(2):224-8.
Score: 0.006
-
Screening and association testing of common coding variation in steroid hormone receptor co-activator and co-repressor genes in relation to breast cancer risk: the Multiethnic Cohort. BMC Cancer. 2009 Jan 30; 9:43.
Score: 0.006
-
Health-related quality of life following a clinical weight loss intervention among overweight and obese adults: intervention and 24 month follow-up effects. Health Qual Life Outcomes. 2006 Jul 17; 4:43.
Score: 0.005
-
Monoclonal antibody recognition of multiple forms of estrogen receptor tagged with [125I]methoxy-iodovinyl estradiol in ovarian carcinomas. J Clin Endocrinol Metab. 1985 Sep; 61(3):412-7.
Score: 0.004
-
Immunocytochemical identification of estrogen receptor in ovarian carcinomas. Localization with monoclonal estrophilin antibodies compared with biochemical assays. Lab Invest. 1985 Sep; 53(3):349-61.
Score: 0.004
-
Maxillary sinus cancer: a study of 33 cases. J Oral Pathol. 1985 Jan; 14(1):27-36.
Score: 0.004
-
Immunohistochemical assessment of estrogen receptor distribution in the human endometrium throughout the menstrual cycle. Lab Invest. 1984 Nov; 51(5):495-503.
Score: 0.004
-
Estrogen receptor determination in endometrial carcinoma: ligand binding assay versus enzyme immunoassay. Anticancer Res. 1995 Mar-Apr; 15(2):649-54.
Score: 0.002
-
Immunocytochemical determination of estrogen receptor, progesterone receptor, and 1,25-dihydroxyvitamin D3 receptor in breast cancer and relationship to prognosis. Cancer Res. 1991 Jan 01; 51(1):239-44.
Score: 0.002
-
Immunohistochemical analysis of estrogen and progesterone receptors in benign breast diseases. Zentralbl Pathol. 1991; 137(3):227-32.
Score: 0.002
-
The use of fine needle aspirates in the evaluation of progesterone receptor content in breast cancer. Acta Cytol. 1990 Jan-Feb; 34(1):27-30.
Score: 0.001
-
Immunocytochemical assay of progesterone receptors in paraffin-embedded specimens of endometrial carcinoma and hyperplasia: a preliminary evaluation. Mod Pathol. 1989 Sep; 2(5):449-55.
Score: 0.001
-
Progesterone receptors in the human heart and great vessels. Lab Invest. 1988 Sep; 59(3):353-6.
Score: 0.001
-
Immunohistochemical analysis of human uterine estrogen and progesterone receptors throughout the menstrual cycle. J Clin Endocrinol Metab. 1988 Aug; 67(2):334-40.
Score: 0.001
-
Estrogen receptor localization in formalin-fixed, paraffin-embedded endometrium and endometriotic tissues. Int J Gynecol Pathol. 1987; 6(2):140-51.
Score: 0.001
-
Squamous-cell carcinoma of the floor of the mouth. Oral Surg Oral Med Oral Pathol. 1978 Apr; 45(4):568-79.
Score: 0.001